An Albumin-Holliday Junction Biomolecular Modular Design for Programmable Multifunctionality and Prolonged Circulation
Authors:
Open Access
- 17 January 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 35 (2) , 214-222
Abstract
Combinatorial properties such as long-circulation and site- and cell-specific engagement need to be built into the design of advanced drug delivery systems to maximize drug payload efficacy. This work introduces a four-stranded oligonucleotide Holliday Junction (HJ) motif bearing functional moieties covalently conjugated to recombinant human albumin (rHA) to give a "plug-and-play" rHA-HJ multifunctional biomolecular assembly with extended circulation. Electrophoretic gel-shift assays show successful functionalization and purity of the individual high-performance liquid chromatography-purified modules as well as efficient assembly of the rHA-HJ construct. Inclusion of an epidermal growth factor receptor (EGFR)-targeting nanobody module facilitates specific binding to EGFR-expressing cells resulting in approximately 150-fold increased fluorescence intensity determined by flow cytometric analysis compared to assemblies absent of nanobody inclusion. A cellular recycling assay demonstrated retained albumin-neonatal Fc receptor (FcRn) binding affinity and accompanying FcRn-driven cellular recycling. This translated to a 4-fold circulatory half-life extension (2.2 and 0.55 h, for the rHA-HJ and HJ, respectively) in a double transgenic humanized FcRn/albumin mouse. This work introduces a novel biomolecular albumin-nucleic acid construct with extended circulatory half-life and programmable multifunctionality due to its modular design.Keywords
Funding Information
- Engineering and Physical Sciences Research Council
- Novo Nordisk Fonden (NNF17OC0028070)
- Villum Fonden (VKR18333)
This publication has 32 references indexed in Scilit:
- A Versatile Platform for Single- and Multiple-Unnatural Amino Acid Mutagenesis in Escherichia coliBiochemistry, 2013
- The ERBB network: at last, cancer therapy meets systems biologyNature Reviews Cancer, 2012
- Combinatorial drug therapy for cancer in the post-genomic eraNature Biotechnology, 2012
- Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptorNature Communications, 2012
- Bromomaleimides: new reagents for the selective and reversible modification of cysteineChemical Communications, 2009
- EGF induces coalescence of different lipid raftsJournal of Cell Science, 2008
- Aptamers come of age – at lastNature Reviews Microbiology, 2006
- The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its LifespanJournal of Experimental Medicine, 2003
- Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2′-O,4′-C-methyleneribonucleosidesTetrahedron Letters, 1998
- LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognitionChemical Communications, 1998